Felix Generics Private Limited is recalling approximately 1.8 million tablets of enrofloxacin, an antibacterial medication sold under various brand names including Pivetal Fluroxin, Covetrus, Vetone Enrosite, and Enrofloxacin. The recall was initiated because certain lots failed stability testing for dissolution, meaning the tablets may not break down properly in the animal's system. This could potentially result in the medication being less effective than intended.
The tablets failed dissolution testing, which can prevent the medication from being absorbed correctly by the animal, potentially leading to treatment failure for bacterial infections.
You have 2 options:
Manufactured for Aspen Veterinary Resources, LTD.
Distributed by Covetrus North America.
Distributed by MWI.
Distributed by Dechra Veterinary Products.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response